PainChek Limited (ASX:PCK)
Australia · Delayed Price · Currency is AUD 0.0350
0.00 (0.00%)
Aug 5, 2025, 3:57 PM AEST
PainChek Market Cap
PainChek has a market cap or net worth of 64.47 million as of August 4, 2025. Its market cap has increased by 31.37% in one year.
Market Cap
64.47M
Enterprise Value
61.59M
Revenue
3.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since January 22, 2018, PainChek's market cap has increased from 39.79M to 64.47M, an increase of 62.03%. That is a compound annual growth rate of 6.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 64.47M | 22.98% |
| Dec 31, 2024 | 52.43M | -1.32% |
| Dec 29, 2023 | 53.12M | 20.53% |
| Dec 30, 2022 | 44.08M | -26.56% |
| Dec 31, 2021 | 60.02M | -30.83% |
| Dec 31, 2020 | 86.76M | -55.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 127.86B |
| Pro Medicus | 32.80B |
| Cochlear | 20.43B |
| Sonic Healthcare | 13.51B |
| Ramsay Health Care | 8.74B |
| Telix Pharmaceuticals | 6.82B |
| Ansell | 4.35B |
| Mesoblast | 3.01B |